1. Document
     XeH Hospital Discharge Report (2.16.840.1.113883.3.1937.99.61.67.10.8)
    1. Header
       XeH CDA recordTarget (2.16.840.1.113883.3.1937.99.61.67.10.1)
      1. datatypelevel
         IPS Address (2.16.840.1.113883.10.22.11)
      2. datatypelevel
         IPS Address (2.16.840.1.113883.10.22.11)
    2. Header
       XeH CDA author (2.16.840.1.113883.3.1937.99.61.67.10.2)
      1. Entry
         IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Header
         IPS CDA Organization (2.16.840.1.113883.10.22.9.1)
        1. datatypelevel
           IPS Address (2.16.840.1.113883.10.22.11)
    3. Header
       XeH CDA dataEnterer (2.16.840.1.113883.3.1937.99.61.67.10.12)
      1. Header
         IPS CDA Organization (2.16.840.1.113883.10.22.9.1)
        1. datatypelevel
           IPS Address (2.16.840.1.113883.10.22.11)
    4. Header
       XeH CDA custodian (2.16.840.1.113883.3.1937.99.61.67.10.5)
      1. Header
         IPS CDA Organization (2.16.840.1.113883.10.22.9.1)
        1. datatypelevel
           IPS Address (2.16.840.1.113883.10.22.11)
    5. Header
       XeH Information Recipient (2.16.840.1.113883.3.1937.99.61.67.10.15)
      1. notype
         PlayingEntity or person with Name (1.3.6.1.4.1.19376.1.3.10.9.18)
      2. notype
         Organization with Name, Addr, Telecom (1.3.6.1.4.1.19376.1.3.10.9.13)
    6. Header
       XeH CDA legalAuthenticator (2.16.840.1.113883.3.1937.99.61.67.10.3)
      1. Header
         IPS CDA Organization (2.16.840.1.113883.10.22.9.1)
        1. datatypelevel
           IPS Address (2.16.840.1.113883.10.22.11)
    7. Header
       XeH Ordering/Referring Provider (2.16.840.1.113883.3.1937.99.61.67.10.4)
    8. Header
       IPS Patient Contacts (2.16.840.1.113883.10.22.2.5)
      1. datatypelevel
         IPS Address (2.16.840.1.113883.10.22.11)
    9. Header
       CDA participant (2.16.840.1.113883.10.12.108)
      1. *
         CDA Person (2.16.840.1.113883.10.12.152)
      2. *
         CDA Organization (2.16.840.1.113883.10.12.151)
    10. Header
       XeH inFulfillmentOf (2.16.840.1.113883.3.1937.99.61.67.10.6)
    11. Header
       CDA documentationOf (2.16.840.1.113883.10.12.110)
      1. *
         CDA AssignedEntity (2.16.840.1.113883.10.12.153)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. *
           CDA Organization (2.16.840.1.113883.10.12.151)
    12. Header
       IPS CDA relatedDocument (2.16.840.1.113883.10.22.2.7)
    13. Header
       XeH ComponentOf HDR (2.16.840.1.113883.3.1937.99.61.67.10.19)
      1. *
         CDA AssignedEntity (2.16.840.1.113883.10.12.153)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      2. *
         CDA AssignedEntity (2.16.840.1.113883.10.12.153)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      3. *
         CDA AssignedEntity (2.16.840.1.113883.10.12.153)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      4. *
         CDA AssignedEntity (2.16.840.1.113883.10.12.153)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      5. Entry
         CDA Place (2.16.840.1.113883.10.12.317)
      6. *
         CDA Organization (2.16.840.1.113883.10.12.151)
    14. Section
       XeH Patient History Section (2.16.840.1.113883.3.1937.99.61.67.10.16)
      1. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    15. Section
       XeH Admission Diagnosis Section (2.16.840.1.113883.3.1937.99.61.67.10.20)
      1. Entry
         XeH Admission Diagnosis (2.16.840.1.113883.3.1937.99.61.67.10.21)
        1. Entry
           IPS Severity Observation (2.16.840.1.113883.10.22.4.25)
        2. Entry
           IPS Certainty Observation (2.16.840.1.113883.10.22.4.19)
    16. Section
       XeH Chief Complaint and Reason for Visit Section (2.16.840.1.113883.3.1937.99.61.67.10.28)
    17. Section
       XeH Problems Section (2.16.840.1.113883.3.1937.99.61.67.10.29)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Problem Concern Entry (2.16.840.1.113883.10.22.4.7)
        1. Entry
           IPS Problem Entry (2.16.840.1.113883.10.22.4.8)
          1. Entry
             IPS Severity Observation (2.16.840.1.113883.10.22.4.25)
          2. Entry
             IPS Certainty Observation (2.16.840.1.113883.10.22.4.19)
          3. Entry
             IPS Problem Status Observation (2.16.840.1.113883.10.22.4.20)
      4. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    18. Section
       XeH Admission Medications Section (2.16.840.1.113883.3.1937.99.61.67.10.31)
      1. Entry
         IPS Medication Statement (2.16.840.1.113883.10.22.4.4)
        1. Entry
           UV Use Period (2.16.840.1.113883.10.21.9.1)
        2. Entry
           IPS Medication Information (detail) (2.16.840.1.113883.10.22.4.2)
          1. Entry
             IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)
        3. Entry
           IPS Body Author (2.16.840.1.113883.10.22.4.14)
          1. Entry
             IPS CDA Device (2.16.840.1.113883.10.22.9.2)
        4. Entry
           UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)
    19. Section
       IPS Allergies and Intolerances Section (2.16.840.1.113883.10.22.3.2)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Allergy and Intolerance Concern (2.16.840.1.113883.10.22.4.5)
        1. Entry
           IPS Allergy or Intolerance (2.16.840.1.113883.10.22.4.1)
          1. Entry
             IPS Reaction Manifestation (2.16.840.1.113883.10.22.4.6)
            1. Entry
               IPS Severity Observation (2.16.840.1.113883.10.22.4.25)
          2. Entry
             IPS Criticality Observation (2.16.840.1.113883.10.22.4.18)
          3. Entry
             IPS Allergy Certainty Observation (2.16.840.1.113883.10.22.10)
          4. Entry
             IPS Allergy Status Observation (2.16.840.1.113883.10.22.4.21)
      4. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    20. Section
       IPS History of Procedures Section (2.16.840.1.113883.10.22.3.4)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Procedure Entry (2.16.840.1.113883.10.22.4.17)
        1. Entry
           IPS Internal Reference (2.16.840.1.113883.10.22.4.31)
      4. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    21. Section
       IPS Immunizations Section (2.16.840.1.113883.10.22.3.5)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Immunization (2.16.840.1.113883.10.22.4.15)
        1. Entry
           IPS Immunization Medication Information (2.16.840.1.113883.10.22.4.16)
          1. Header
             IPS CDA Organization (2.16.840.1.113883.10.22.9.1)
            1. datatypelevel
               IPS Address (2.16.840.1.113883.10.22.11)
        2. Entry
           CDA Author (Body) (2.16.840.1.113883.10.12.318)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. Entry
             CDA Device (2.16.840.1.113883.10.12.315)
          3. *
             CDA Organization (2.16.840.1.113883.10.12.151)
      4. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    22. Section
       IPS Medical Devices Section (2.16.840.1.113883.10.22.3.6)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Medical Device (2.16.840.1.113883.10.22.4.26)
      4. Entry
         IPS Procedure Entry (2.16.840.1.113883.10.22.4.17)
        1. Entry
           IPS Internal Reference (2.16.840.1.113883.10.22.4.31)
      5. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    23. Section
       IPS History of Past Illness Section (2.16.840.1.113883.10.22.3.7)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Problem Concern Entry (2.16.840.1.113883.10.22.4.7)
        1. Entry
           IPS Problem Entry (2.16.840.1.113883.10.22.4.8)
          1. Entry
             IPS Severity Observation (2.16.840.1.113883.10.22.4.25)
          2. Entry
             IPS Certainty Observation (2.16.840.1.113883.10.22.4.19)
          3. Entry
             IPS Problem Status Observation (2.16.840.1.113883.10.22.4.20)
      4. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    24. Section
       XeH Family History Section (2.16.840.1.113883.3.1937.99.61.67.10.26)
      1. Entry
         XeH Family History Organizer (2.16.840.1.113883.3.1937.99.61.67.10.27)
        1. Entry
           XeH Family History Observation (2.16.840.1.113883.3.1937.99.61.67.10.34)
          1. Entry
             XeH Age Observation (2.16.840.1.113883.3.1937.99.61.67.10.33)
          2. Entry
             XeH Family History Death Observation (2.16.840.1.113883.3.1937.99.61.67.10.35)
    25. Section
       IPS Functional Status Section (2.16.840.1.113883.10.22.3.8)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Survey Panel (2.16.840.1.113883.10.22.4.42)
        1. Entry
           IPS Survey Observation (2.16.840.1.113883.10.22.4.43)
      4. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    26. Section
       IPS Social History Section (2.16.840.1.113883.10.22.3.10)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Social History Tobacco Use (2.16.840.1.113883.10.22.4.34)
      4. Entry
         IPS Social History Alcohol Use (2.16.840.1.113883.10.22.4.35)
      5. Entry
         IPS Social History Observation (2.16.840.1.113883.10.22.4.48)
      6. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    27. Section
       IHE Hospital Course Section (1.3.6.1.4.1.19376.1.5.3.1.3.5)
    28. Section
       IPS Medication Summary Section (2.16.840.1.113883.10.22.3.1)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Medication Statement (2.16.840.1.113883.10.22.4.4)
        1. Entry
           UV Use Period (2.16.840.1.113883.10.21.9.1)
        2. Entry
           IPS Medication Information (detail) (2.16.840.1.113883.10.22.4.2)
          1. Entry
             IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)
        3. Entry
           IPS Body Author (2.16.840.1.113883.10.22.4.14)
          1. Entry
             IPS CDA Device (2.16.840.1.113883.10.22.9.2)
        4. Entry
           UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)
      4. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    29. Section
       IPS Vital Signs Section (2.16.840.1.113883.10.22.3.16)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Vital Signs Organizer (2.16.840.1.113883.10.22.4.44)
        1. Entry
           IPS Vital Signs Observation (2.16.840.1.113883.10.22.4.45)
      4. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    30. Section
       IPS Results Section (2.16.840.1.113883.10.22.3.14)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Result Organizer (2.16.840.1.113883.10.22.4.9)
        1. Entry
           CDA Performer (Body) (2.16.840.1.113883.10.12.323)
          1. *
             CDA AssignedEntity (2.16.840.1.113883.10.12.153)
            1. *
               CDA Person (2.16.840.1.113883.10.12.152)
            2. *
               CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           IPS Body Author (2.16.840.1.113883.10.22.4.14)
          1. Entry
             IPS CDA Device (2.16.840.1.113883.10.22.9.2)
        3. Entry
           IPS Laboratory Result Observation (2.16.840.1.113883.10.22.4.13)
          1. Entry
             IPS Body Author (2.16.840.1.113883.10.22.4.14)
            1. Entry
               IPS CDA Device (2.16.840.1.113883.10.22.9.2)
          2. Entry
             IPS Comment Activity (2.16.840.1.113883.10.22.4.22)
        4. Entry
           IPS Radiology Result Observation (2.16.840.1.113883.10.22.4.12)
          1. Entry
             IPS Body Author (2.16.840.1.113883.10.22.4.14)
            1. Entry
               IPS CDA Device (2.16.840.1.113883.10.22.9.2)
          2. Entry
             IPS Comment Activity (2.16.840.1.113883.10.22.4.22)
        5. Entry
           IPS Pathology Result Observation (2.16.840.1.113883.10.22.4.11)
          1. Entry
             IPS Body Author (2.16.840.1.113883.10.22.4.14)
            1. Entry
               IPS CDA Device (2.16.840.1.113883.10.22.9.2)
          2. Entry
             IPS Comment Activity (2.16.840.1.113883.10.22.4.22)
        6. Entry
           IPS Result Observation (2.16.840.1.113883.10.22.4.10)
          1. Entry
             IPS Body Author (2.16.840.1.113883.10.22.4.14)
            1. Entry
               IPS CDA Device (2.16.840.1.113883.10.22.9.2)
          2. Entry
             IPS Comment Activity (2.16.840.1.113883.10.22.4.22)
        7. Entry
           IPS Specimen Collection (2.16.840.1.113883.10.22.4.30)
        8. Entry
           IPS Comment Activity (2.16.840.1.113883.10.22.4.22)
        9. Entry
           IPS ObservationMedia (2.16.840.1.113883.10.22.4.23)
          1. Entry
             CDA Performer (Body) (2.16.840.1.113883.10.12.323)
            1. *
               CDA AssignedEntity (2.16.840.1.113883.10.12.153)
              1. *
                 CDA Person (2.16.840.1.113883.10.12.152)
              2. *
                 CDA Organization (2.16.840.1.113883.10.12.151)
          2. Entry
             CDA Author (Body) (2.16.840.1.113883.10.12.318)
            1. *
               CDA Person (2.16.840.1.113883.10.12.152)
            2. Entry
               CDA Device (2.16.840.1.113883.10.12.315)
            3. *
               CDA Organization (2.16.840.1.113883.10.12.151)
      4. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    31. Section
       IHE Discharge Diagnosis Section (1.3.6.1.4.1.19376.1.5.3.1.3.7)
      1. Entry
         eHDSI Problem Concern (1.3.6.1.4.1.19376.1.5.3.1.4.5.2)
        1. Entry
           eHDSI Problem (1.3.6.1.4.1.12559.11.10.1.3.1.3.7)
          1. Entry
             eHDSI Severity (1.3.6.1.4.1.12559.11.10.1.3.1.3.8)
          2. Entry
             eHDSI Certainty Observation (1.3.6.1.4.1.12559.11.10.1.3.1.3.49)
          3. Entry
             eHDSI Problem Status Observation (1.3.6.1.4.1.12559.11.10.1.3.1.3.9)
          4. Entry
             eHDSI Health Status Observation (1.3.6.1.4.1.12559.11.10.1.3.1.3.10)
          5. Entry
             eHDSI Comment (1.3.6.1.4.1.12559.11.10.1.3.1.3.11)
            1. Header
               eHDSI Author (2.16.840.1.113883.3.1937.777.11.10.102)
              1. Entry
                 eHDSI Device (2.16.840.1.113883.3.1937.777.11.10.129)
              2. *
                 eHDSI Organization (2.16.840.1.113883.3.1937.777.11.10.111)
          6. Entry
             eHDSI Care Team Act (1.3.6.1.4.1.12559.11.10.1.3.1.3.48)
            1. Entry
               eHDSI Internal Reference (1.3.6.1.4.1.12559.11.10.1.3.1.3.14)
    32. Section
       XeH Discharge Medications Section (2.16.840.1.113883.3.1937.99.61.67.10.32)
      1. Entry
         IPS Medication Statement (2.16.840.1.113883.10.22.4.4)
        1. Entry
           UV Use Period (2.16.840.1.113883.10.21.9.1)
        2. Entry
           IPS Medication Information (detail) (2.16.840.1.113883.10.22.4.2)
          1. Entry
             IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)
        3. Entry
           IPS Body Author (2.16.840.1.113883.10.22.4.14)
          1. Entry
             IPS CDA Device (2.16.840.1.113883.10.22.9.2)
        4. Entry
           UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)
    33. Section
       IPS Plan of Care Section (2.16.840.1.113883.10.22.3.9)
      1. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      2. Entry
         CDA Informant (Body) (2.16.840.1.113883.10.12.319)
        1. *
           CDA AssignedEntity (2.16.840.1.113883.10.12.153)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. *
             CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA RelatedEntity (2.16.840.1.113883.10.12.316)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
      3. Entry
         IPS Planned Observation (2.16.840.1.113883.10.22.4.41)
      4. Entry
         IPS Planned Procedure (2.16.840.1.113883.10.22.4.38)
        1. Entry
           IPS Internal Reference (2.16.840.1.113883.10.22.4.31)
      5. Entry
         IPS Planned Encounter (2.16.840.1.113883.10.22.4.40)
      6. Entry
         IPS Planned Immunization (2.16.840.1.113883.10.22.4.47)
        1. Entry
           IPS Immunization Medication Information (2.16.840.1.113883.10.22.4.16)
          1. Header
             IPS CDA Organization (2.16.840.1.113883.10.22.9.1)
            1. datatypelevel
               IPS Address (2.16.840.1.113883.10.22.11)
        2. Entry
           CDA Author (Body) (2.16.840.1.113883.10.12.318)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. Entry
             CDA Device (2.16.840.1.113883.10.12.315)
          3. *
             CDA Organization (2.16.840.1.113883.10.12.151)
      7. Entry
         IPS Planned Act (2.16.840.1.113883.10.22.4.39)
        1. Entry
           CDA Performer (Body) (2.16.840.1.113883.10.12.323)
          1. *
             CDA AssignedEntity (2.16.840.1.113883.10.12.153)
            1. *
               CDA Person (2.16.840.1.113883.10.12.152)
            2. *
               CDA Organization (2.16.840.1.113883.10.12.151)
        2. Entry
           CDA Author (Body) (2.16.840.1.113883.10.12.318)
          1. *
             CDA Person (2.16.840.1.113883.10.12.152)
          2. Entry
             CDA Device (2.16.840.1.113883.10.12.315)
          3. *
             CDA Organization (2.16.840.1.113883.10.12.151)
      8. Section
         IPS Translation Section (2.16.840.1.113883.10.22.3.15)
    34. Section
       Hospital Discharge Studies Summary Section (2.16.840.1.113883.10.20.22.2.16)